BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38433573)

  • 21. Optical Genome Mapping in Routine Human Genetic Diagnostics-Its Advantages and Limitations.
    Dremsek P; Schwarz T; Weil B; Malashka A; Laccone F; Neesen J
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. nanotatoR: a tool for enhanced annotation of genomic structural variants.
    Bhattacharya S; Barseghyan H; Délot EC; Vilain E
    BMC Genomics; 2021 Jan; 22(1):10. PubMed ID: 33407088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.
    Coccaro N; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Minervini CF; Minervini A; Conserva MR; Redavid I; Parciante E; Macchia MG; Specchia G; Musto P; Albano F
    Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of cryptic balanced chromosomal rearrangements using high-resolution optical genome mapping.
    Zhang S; Pei Z; Lei C; Zhu S; Deng K; Zhou J; Yang J; Lu D; Sun X; Xu C; Xu C
    J Med Genet; 2023 Mar; 60(3):274-284. PubMed ID: 35710108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical genome mapping unveils hidden structural variants in neurodevelopmental disorders.
    Schrauwen I; Rajendran Y; Acharya A; Öhman S; Arvio M; Paetau R; Siren A; Avela K; Granvik J; Leal SM; Määttä T; Kokkonen H; Järvelä I
    Sci Rep; 2024 May; 14(1):11239. PubMed ID: 38755281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics.
    Dai P; Zhu X; Pei Y; Chen P; Li J; Gao Z; Liang Y; Kong X
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1936. PubMed ID: 35384386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare structural variants, aneuploidies, and mosaicism in individuals with Mullerian aplasia detected by optical genome mapping.
    Brakta S; Hawkins ZA; Sahajpal N; Seman N; Kira D; Chorich LP; Kim HG; Xu H; Phillips JA; Kolhe R; Layman LC
    Hum Genet; 2023 Apr; 142(4):483-494. PubMed ID: 36797380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of trio-based whole exome sequencing and optical genome mapping reveals a cryptic balanced translocation that causes unbalanced chromosomal rearrangements in a family with multiple anomalies.
    Xie M; Xue J; Zhang Y; Zhou Y; Yu Q; Li H; Li Q
    Front Genet; 2023; 14():1248544. PubMed ID: 37745854
    [No Abstract]   [Full Text] [Related]  

  • 29. Optical Genome Mapping: A Revolutionary Tool for "Next Generation Cytogenomics Analysis" with a Broad Range of Diagnostic Applications in Human Diseases.
    Garcia-Heras J
    J Assoc Genet Technol; 2021; 47(4):191-200. PubMed ID: 34897113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and initial clinical evaluation of optical genome mapping in the diagnosis of structural variations].
    Hao N; Zhou J; Li MM; Luo WW; Zhang HZ; Qi QW; Jiang YL; Zhou XY; Yang K; Chen H; Pan HJ; Zhu JT; Liu J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 May; 56(5):632-639. PubMed ID: 35644979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical genome mapping identifies clinically relevant genomic rearrangements in prostate cancer biopsy sample.
    Shim Y; Lee J; Seo J; Park CK; Shin S; Han H; Lee ST; Choi JR; Chung BH; Choi YD
    Cancer Cell Int; 2022 Oct; 22(1):306. PubMed ID: 36209207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood
    Brandes D; Yasin L; Nebral K; Ebler J; Schinnerl D; Picard D; Bergmann AK; Alam J; Köhrer S; Haas OA; Attarbaschi A; Marschall T; Stanulla M; Borkhardt A; Brozou T; Fischer U; Wagener R
    Hemasphere; 2023 Aug; 7(8):e925. PubMed ID: 37469802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of complex and cryptic chromosomal rearrangements by optical genome mapping.
    Shi S; Huang P; Yan R; Li R
    Mol Cytogenet; 2023 Apr; 16(1):5. PubMed ID: 37101225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation.
    Sahajpal NS; Mondal AK; Vashisht A; Singh H; Pang AWC; Saul D; Nivin O; Hilton B; DuPont BR; Kota V; Savage NM; Hastie AR; Chaubey A; Kolhe R
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A framework for the clinical implementation of optical genome mapping in hematologic malignancies.
    Levy B; Kanagal-Shamanna R; Sahajpal NS; Neveling K; Rack K; Dewaele B; Olde Weghuis D; Stevens-Kroef M; Puiggros A; Mallo M; Clifford B; Mantere T; Hoischen A; Espinet B; Kolhe R; Solé F; Raca G; Smith AC
    Am J Hematol; 2024 Apr; 99(4):642-661. PubMed ID: 38164980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
    Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
    Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes.
    Baelen J; Dewaele B; Debiec-Rychter M; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Vanden Bempt I
    J Mol Diagn; 2024 May; 26(5):374-386. PubMed ID: 38395407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical Genome Mapping Identifies a Novel Unbalanced Translocation Between Chromosomes 4q and 6q Leading to Feeding Difficulties and Hypotonia in a Neonate: A Case Report.
    Wang Y; Bi S; Shi X; Dai L
    Appl Clin Genet; 2024; 17():63-69. PubMed ID: 38828444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
    Barford RG; Whittle E; Weir L; Fong FC; Goodman A; Hartley HE; Allinson LM; Tweddle DA
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
    Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
    Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.